AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC. Gottgens EL, Bussink J, Ansems M, Hammond EM, et al. Radiother Oncol 2020;149:1-7.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gottgens EL, Bussink J, Ansems M, Hammond EM, et al. AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC. Radiother Oncol 2020;149:1-7.
PMID: 32361013